Novo Nordisk ADR earnings beat by $0.05, revenue topped estimates
- ByInvesting.com-
Investing.com - Novo Nordisk ADR (NYSE: NVO) reported fourth quarter EPS of $0.88, $0.05 better than the analyst estimate of $0.83. Revenue for the quarter came in at $7.06B versus...